clinical trials

Merck bags global rights to NGM NASH drug, plans phase 2b trial
Merck bags global rights to NGM NASH drug, plans phase 2b trial
Fierce Biotech
Merck
NASH
NGM Biopharmaceuticals
type 2 diabetes
clinical trials
MK-3655
Flag link:
Deciphera expands cancer trial after seeing early data
Deciphera expands cancer trial after seeing early data
Fierce Biotech
Deciphera
DCC-3014
TGCTs
cancer
clinical trials
Flag link:
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
clinical trials
Takeda
Zinfandel Pharmaceuticals
pioglitazone
Alzheimer's disease
Boehringer Ingelheim
BI 409306
Merck
verubecestat
Celgene
MS
ozanimod
Incyte
ID01
melanoma
vTv Therapeutics
azeliragon
Roche
Tecentriq
Exelixis
colorectal cancer
JNJ
atabacestat
Sareptat Therapeutics
DMD
Exondys 51
Alkermes
ALKS-5461
clinical depression
Flag link:
Upcoming events – Phase III readouts loom for Urogen and Mediwound
Upcoming events – Phase III readouts loom for Urogen and Mediwound
EP Vantage
Urogen
clinical trials
UGN-101
urothelial cancer
MediWound
NexoBrid
devices
burns
Flag link:
As with children studies, Supernus ADHD drug shows fast onset of action in adolescents
As with children studies, Supernus ADHD drug shows fast onset of action in adolescents
Endpoints
Supernus Pharmaceuticals
ADHD
clinical trials
SPN-812
Flag link:
Diabetes tech execs talk patient-centric design, device development & trust
Diabetes tech execs talk patient-centric design, device development & trust
Mass Device
diabetes
patients
devices
clinical trials
Flag link:
Idorsia's selatogrel hits goals in phase 2 cardiovascular trials
Idorsia's selatogrel hits goals in phase 2 cardiovascular trials
Fierce Biotech
Idorsia
selatogrel
clinical trials
coronary artery disease
acute myocardial infarctions
Flag link:
Teva reports positive results for fremanezumab in phase IIIb migraine trial
Teva reports positive results for fremanezumab in phase IIIb migraine trial
Pharmaceutical Business Review
Teva Pharmaceutical
migraines
clinical trials
fremanezumab
Flag link:
Sophiris, Stock Sliding After Cancer Drug Data, Still Plans Phase 3
Sophiris, Stock Sliding After Cancer Drug Data, Still Plans Phase 3
Xconomy
Sophris
prostate cancer
clinical trials
Topsalysin
Flag link:
Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial
Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial
Reuters
Eli Lilly
psoriatic arthritis
Taltz
AbbVie
Humira
clinical trials
Flag link:
15 For ’19: Key Clinical Data To Watch For Next Year (Part 1)
15 For ’19: Key Clinical Data To Watch For Next Year (Part 1)
Xconomy
clinical trials
Alzheimer's disease
Biogen
Duchenne Muscular Dystrophy
Pfizer
Solid Biosciences
Sarepta Therapeutics
hemophilia A
Biomarin
Multiple Myeloma
Celgene
Bluebird Bio
Amgen
solid tumors
Bristol-Myers Squibb
Nektar Therapeutics
age-related macular degeneration
Regenxbio
SAGE Therapeutics
MorphoSys
Flag link:
Sensorion’s vertigo drug hits tolerability endpoint in phase 2
Sensorion’s vertigo drug hits tolerability endpoint in phase 2
Fierce Biotech
Sensorion
vertigo
seliforant
clinical trials
Flag link:
AstraZeneca mines for positives in Imfinzi's failed Mystic lung cancer trial
AstraZeneca mines for positives in Imfinzi's failed Mystic lung cancer trial
Fierce Pharma
AstraZeneca
Imfinizi
clinical trials
immuno-oncology
Flag link:
NeuroRx plans pivotal trial after seeing hints of efficacy in suicidal patients
NeuroRx plans pivotal trial after seeing hints of efficacy in suicidal patients
Fierce Biotech
NeuroRx
NRX-101
suicidal bipolar depression
clinical trials
Flag link:
Vanda preps Hetlioz for a new market
Vanda preps Hetlioz for a new market
EP Vantage
clinical trials
Vanda Pharmaceuticals
Hetlioz
Smith-Magenis syndrome
Flag link:
Lawsuit Charges FDA, NIH With Failing to Follow Established Law for Reporting of Clinical Trial Data
Lawsuit Charges FDA, NIH With Failing to Follow Established Law for Reporting of Clinical Trial Data
BioSpace
FDA
clinical trials
NIH
Flag link:
Amgen Contributes to Nonprofit to Support Greater Diversity in Clinical Trials
Amgen Contributes to Nonprofit to Support Greater Diversity in Clinical Trials
BioSpace
Amgen
clinical trials
diversity
minorities
oncology
Flag link:
Ra Pharma files $100M round as Soliris rival clears phase 2 trial
Ra Pharma files $100M round as Soliris rival clears phase 2 trial
Fierce Biotech
Ra Pharma
Soliris
clinical trials
myasthenia gravis
zilucoplan
Flag link:
Multiple Myeloma Research Foundation Bets on Adaptive Platform Clinical Trial Design
Multiple Myeloma Research Foundation Bets on Adaptive Platform Clinical Trial Design
Xtalks
clinical trials
Multiple Myeloma
adaptive trial design
AbbVie
Celgene
Eli Lilly
Genentech
Janssen
Takeda
Flag link:
Axovant dumps nelotanserin in retreat from small molecule R&D
Axovant dumps nelotanserin in retreat from small molecule R&D
Fierce Biotech
Axovant
nelotanserin
dementia with Lewy bodies
clinical trials
R&D
small molecule drugs
Flag link:

Pages